Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
Using the technology and making it work for purpose are two different things. And the U.S. leads all countries in terms of full implementation, at 24% (vs. 19% for China).
Several state attorneys general have issued notices to residents regarding the Change Healthcare breach, asking them to sign up for credit monitoring and identity theft protection.
Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.
A full court hearing to determine the fate of the FTC ban on noncompete clauses will be scheduled before Aug 31. For now, a judge has issued a preliminary injunction.